Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2002

View Archived Issues

Malaria vaccine produced in milk of transgenic animals protective in monkeys

Mechanism of hypoglycemic effect of Acrp30 examined in mice

Airways-selective potassium channel opener in development by Novartis for asthma Rx

NVP-ABE-171: a PDE4 inhibitor with better activity than Ariflo in rodent models of lung inflammation

Vertex updates its progress and plans for 2002

INGN-201 does not integrate into the host cell genome, demonstrates activity as anticancer vaccine

INGN-251 endowed with both cell-killing and antimetastatic properties according to recent data

Encouraging phase Ia results of XTL-002 in hepatitis C

Peptor to begin phase II trial of DiaPep277 in treatment of LADA

4SC and Wilex enter research collaboration for second-generation uPA inhibitors

Disappointing results from phase III trial of SnET2 in wet AMD

Amerimmune initiates phase Ib study of Cytolin in HIV patients

Positive preliminary results from Corixa's phase III trial of RC-529 adjuvant

Pfizer discovers endothelin receptor antagonists selective for ETA subtype

Indole-based inhibitors of angiogenesis designed at Abbott

Grelan researchers identify benzothiazole COX-2 inhibitors useful for inflammation

Selective alpha1A-adrenoceptor antagonists claimed for therapy of BPH

New compounds from Lilly useful for treatment of conditions associated with glutamate hypofunction

Pharmacia presents protein kinase inhibitors and their potential uses in recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...